Drugs / Lactobacillus paracasei
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT04566549 | Jul → Dec 2020 | skin disorder | GenMont Biotech Incorporation | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT07579403 | Jan 2023 → Jun 2024 | dental caries | The Affiliated Hospital of Qingdao University | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT07296718 Comparator | May → Nov 2023 | neonatal sepsis, perinatal necrotizing enterocolitis | Madiha, MPhil | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lactobacillus paracasei | “Contains Lactobacillus paracasei. Used for tooth brushing three times daily.” NCT07579403 ↗2“Heat-killed Lactobacillus paracasei powders (5x10\^8 cells/ g-shampoo).” NCT04566549 ↗ |
| Route | Topical | “the benefit effects of heat-killed Lactobacillus paracasei shampoo on scalp and hair healthcare” NCT04566549 ↗ |